Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether stereotactic body radiation therapy (SBRT)
combined with checkpoint blockaded immunotherapy (CBI) will improve the response to the
anticancer treatment compared to CBI alone in patients with advanced metastatic cancer.